The foreshadow of a second wave:
An analysis of current COVID-19 fatalities in Germany
Matthias Linden1,2 , Jonas Dehning1 , Sebastian B. Mohr1 , Jan Mohring3 , Michael
Meyer-Hermann4,5 , Iris Pigeot6,7 , Anita Schöbel5,8 , Viola Priesemann1,9,∗
1

arXiv:2010.05850v2 [q-bio.PE] 27 Oct 2020

5

Max Planck Institute for Dynamics and Self-Organization, Am Fassberg 17, 37077 Göttingen.
2
Institute for Theoretical Physics, Leibniz University, 30167 Hannover.
3
Fraunhofer Institute for Industrial Mathematics, Fraunhofer-Platz 1, 67663 Kaiserslautern.
4
Department of Systems Immunology and Integrated Centre of Systems Biology (BRICS),
Helmholtz Centre for Infection Research, Rebenring 56, 38106 Braunschweig.
Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, 38106 Braunschweig.
6
Leibniz Institute for Prevention Research and Epidemiology – BIPS, Achterstraße 30, 28359 Bremen.
7
University Bremen, Faculty 03: Mathematics/Computer Science, Bibliothekstraße 5, 28359 Bremen.
8
Fachbereich Mathematik, University Kaiserslautern, Postfach 3049, 67663 Kaiserslautern.
9
Department of Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen.
∗
Correspondence should be addressed to viola.priesemann@ds.mpg.de
A German version of the manuscript is appended after supplemental material.
(Dated: October 28, 2020)

A second wave of SARS-CoV-2 is unfolding in dozens
of countries. Compared to the first wave, this second
wave manifests itself strongly in newly reported cases, but
less so in death counts. However, already the increasing
case numbers put the mitigation strategy at risk, because
with case numbers being too high, local tipping points
are crossed, which makes the control increasingly difficult,
impedes the targeted protection of the vulnerable people,
and leads to self-accelerating spread [1, 2].
Importantly, a tipping point is reached when case numbers surpass the test-trace-and-isolate (TTI) capacity of
the local health authority, thus potentially long before
hospitals are overwhelmed [1]: When TTI breaks down,
testing and tracing can only be carried out insufficiently
and with considerable delay, which leads to more and
more missed chains of infections. Thereby increasingly
more SARS-CoV-2 carriers remain unnoticed, and thus
transmit the virus inadvertently – also to people at risk.
As unaware carriers are strong drivers of the spread of
SARS-CoV-2, the case numbers start to rise more quickly,
and the spread spills over to the vulnerable population.
In the following, we present evidence for a second wave
and the crossing of this tipping point.
In Germany, as in many other countries, the emergence
of the second wave has been questioned, because only the
case numbers have been rising since July, while hospitals
were not overwhelmed and death numbers stayed almost
constant (Fig. 1). We investigated this apparent discrepancy using age-stratified case and death reports [3], and
an age-dependent infection fatality rate (IFR). The IFR
is derived from a meta-analysis of seroprevalence studies
and extensive PCR tracing programs [4]. Approximately,
the IFR increases by a factor of 10 for every 20 years of
age, being about 10% at age 82. From this age-dependent
IFR we predict the temporal evolution of the COVID-19associated deaths by delaying each age group’s observed
weekly cases by two weeks and multiplying by the IFR
(see supplementary material).

FIG. 1. The number of weekly COVID-19 cases (left), and the
number of predicted and actual COVID-19-associated deaths
are displayed for each age group (middle). The observed
number deaths (black) in each age group matches well the
predicted deaths calculated from the case numbers (color)
using an age-dependent infection-fatality rate from a metaanalysis[4]. Despite a rise in total reported cases since mid July
(bottom), cases in the older age groups only started to rise in
September (blue arrows). As a consequence, a rise in deaths
is expected to unfold soon (right). The forecast scenarios
A and B (gray, right column) predict a further increase in
case numbers and deaths. The recent rise of infections in the
older age groups together with the overall rise in cases clearly
indicates a loss of control over the spreading and the start of
a second wave.

2
The temporal evolution of the predicted COVID-19associated deaths (color) matches the actually observed
ones (black) well in each age group (Fig. 1, right). Even
the absolute numbers match, suggesting a low fraction
of unobserved SARS-CoV-2 infection chains. This agestratified analysis plausibly resolves the apparent discrepancy between the total reported infections and deaths:
The rise in reported cases has been mainly driven by
younger generations (younger than 60), who contribute
only little to the absolute death counts, whereas the elderly (60+ years) managed to maintain low case numbers
until recently. However, in September cases among the
elderly started to increase steeply. This finding is not confounded by increased testing, because the test numbers in
that age group stayed almost constant [3]. This spill-over
to the elderly strongly suggests a failure to protect the
vulnerable people due to an increased number of unaware
SARS-CoV-2 carriers. Moreover, this loss of control over
the spread is also marked by the increase of the reproduction number R since begin of October (Table I). The
spill-over and the increase of R are clear signatures of
crossing the tipping point to uncontrolled spread.
During summer 2020, the age groups 60+ apparently
were protected well: If the virus had been spreading
independently equally among all age groups, an estimated
1.3% to 2.0% of the infected would have died (calculated
from the IFR in [4]). However, the case fatality rate
CFR was only 0.39% in August (Table I). Now, with
the strongly increasing number of infections among the
elderly (Fig. 1), the CFR will most likely increase soon.
This indicates that protecting the people at risk might
be possible whilst case numbers are low, but likely fails
under high COVID-19 incidence.
For the coming two weeks, the already reported cases
clearly predict that the number of weekly deaths will
almost double. Beyond two weeks forecasts are difficult,
because the death counts depend on the not-yet-reported
cases. To account for this uncertainty, we display two
future scenarios, where in (A) we assume a linear increase,
and in (B) an exponential increase in cases (see supplementary material). The resulting forecasts range between

500 and 800 weekly deaths in early November, but case
numbers might even grow faster in case the second wave
fully unfolds.
If the test-trace-and-isolate (TTI) system is overwhelmed and stops to function as a powerful means of
control, mitigation of the spread breaks down and the rise
of case numbers accelerates [1]. Thus, the current development in Germany puts the past successful management
of the pandemic seriously at risk. To re-establish control
and to avoid crossing the tipping point when the TTI
capacity is exceeded, case numbers have to be lowered
without further delay. Otherwise the control of the spread
and the protection of vulnerable people will inevitably
require much more restrictive measures – at latest when
the hospital capacity is reached.
Number of
Weeks
Period
Jul
4
Aug
4
early Sep 3
late Sep 2
early Oct 2

Number of
Cases Deaths
pred. obs.
14163 122.5 146
32273 156.3 127
30493 214.4 184
28737 281 286
66796 741 -

Metrics
CFR R
[%] (RKI)
1.0 1.11
.39 1.06
.6
1.10
.99 1.16
1.31

TABLE I. This table summarizes the data presented in
Fig. 1. For each time-period in summer 2020, the number
of COVID-19 infections (“cases”) are displayed together with
the number of deaths as observed (obs.) and as predicted
(pred.) from the age-dependent IFR [4]. For correct association
between case and death, the number of deaths have been
advanced by 2 weeks. Predicted and observed deaths deviate
less than 20% from each other. As metrics, the case fatality
rate (CFR) is calculated as ratio between observed deaths and
cases. For comparison: If infections were evenly distributed
across the population and no infection remained undetected,
the CFR would be equal to the theoretical infection fatality
rate (IFR) for the German population, i.e. 1.61 with a 95%
confidence interval of [1.29;2.02] [4]. The last column displays
the reproduction number R as reported by the Robert Koch
Institute (RKI).

3
SUPPLEMENTARY MATERIAL

a. Data sources For Germany, the age-stratified data
used in this document was retrieved from the national
health agency, the Robert Koch Institute (RKI): both the
number of reported SARS-CoV-2 cases and the number of
deaths are available in age groups of ten years [3], and the
reported cases are also available with 5-year stratification
up to the age of 80 from [5]. It was verified that the
number of cases in the two sources matches. The time
points of the case and death numbers correspond to their
reporting dates, and not necessarily to the actual testing
or date of death.
The population age distribution of Germany was retrieved from the United Nation’s database [6].
b. IFR calculation The overall goal is to estimate
death numbers from past reported cases per age group
and compare them to the observed number of deaths.
We used an age-dependent infection-fatality rate (IFR)
equation, following recent meta-studies [4, 7]: Let a be
the age of an infected person. Then the infection fatality
rate for this age is estimated as
1

IFR(a) = 0.1 · 10 20

(a−82)

(1)

This equation formalizes that at 82 years, the IFR is 10%
and decreases by a factor of 10 every 20 years. The age
group 100+ is treated separately as 60%, in accordance
with the supplementary calculations in [4]. In our analysis, we omit cases below the age of 20, as the weekly
reported death numbers in that group are too low for any
meaningful analysis. The equation (1) is very close to the
published one [4], but has been rounded to integers for
simplicity. For comparison see table II.
As reported cases are available with 5-year stratification,
equation (1) was evaluated centered in the respective age
group. For instance, the IFR of the age group 40-44 is
approximated as:
1

IFR40−44 = IFR(42) = 0.1 · 10 20

(42−82)

= 0.1%

(2)

One has to distinguish this IFR calculation from the
CFR calculation which we calculate by simply dividing
the number of deaths by the observed cases two weeks
before, as discussed in more detail in paragraph h.
c. Estimating the number of deaths from the reported
SARS-CoV-2 cases The number of deaths is estimated
by multiplying the published weekly number of reported
cases in 5-years-wide age groups by the associated IFR
(equation (2)). To obtain the time point of the expected
number of deaths, we delayed the number of reported
cases by two weeks. This accounts for a one week delay
between infection and case reporting, and a three weeks
delay between infection and death. Thus, the total delay
of two weeks between reported case and death amounts
to the difference between the infection-case and infectiondeath delay. In addition, two weeks matches a median
delay of 10 days, which can be derived from individual

case histories supplied by the RKI’s publicly available
database [8].
An alternative approach would have been to take those
case histories, infer a delay-distribution between reporting
and death with a one-day temporal resolution and predict
daily deaths. Unfortunately, the age-groups of this dataset
are between 20 and 25 years wide, compared to 5 year
groups with weekly temporal resolution [5]. Due to the
strong age-specificity of the IFR we opted for smaller
age-groups.
The observed number of deaths is only available in
10-years-wide age groups. Thus, to match the coarser
stratification, we summed the corresponding two 5-yearswide age groups for all the plots.
d. Uncertainties of predictions Our estimations features a number of uncertainties: The IFR probably decreased over the course of the pandemic because of better
treatments. This leads to some overestimation of the
IFR as reported by Levin et al [4], which uses data from
early in the pandemic. A fraction of cases remains unobserved, and people at risk may protect themselves better
than earlier in the pandemic. Moreover, the assumed
two-week delay between case detection and death is an
approximation, the observed delay of individual cases features a wider distribution. Overall however, the evidence
indicates that in Germany half or more of all cases are currently detected [9]. In relative numbers across age-groups,
uncertainties are smaller, because systematic errors in the
IFR and the delay approximations are expected to effect
all age groups similarly.
e. Accounting for non-matching age groups If reported cases are not available with a 5-year stratification,
but only coarser , we distribute the reported cases of the
coarser age groups in 5-years-wide age groups, proportional to the population-age distribution of the respective
country [6]. This approach is necessary for ages above 80
years for Germany, where only 10-years-wide age groups
are available: 80-89, 90-99 and 100+.
f. Prediction We consider two distinct scenarios for
the future spread of the virus. Scenario A is a linear
extrapolation fitted to the reported cases in the respective
age groups over the last 5 weeks, which we chose since
linear growth can reflect the local and heterogeneous
spreading of SARS-CoV-2. Furthermore, Scenario B is an
exponential forecast using the reproduction rate R0 = 1.2
given by the RKI [3] in early October and represents
a worser scenario. For the forecast, the corresponding
weekly increase of 37.5% is applied to the latest week of
age-stratified case numbers.
g. Effective infection fatality rate The effective infection fatality rate IFReff is defined as the infection fatality
rate given the age distribution of reported cases. It is
calculated by weighting the IFR of the age groups (eq. (2))
by the number of current reported cases. This approach
to calculate the effective IFR accounts for varying case
distributions within the age groups, which therefore leads
to a time-dependence of the effective IFR. Note that this
IFReff is not a case-fatality rate, because only the age

4

[1] Sebastian Contreras, Jonas Dehning, Matthias Loidolt,
F. Paul Spitzner, Jorge H. Urrea-Quintero, Sebastian B. Mohr, Michael Wilczek, Johannes Zierenberg,
Michael Wibral, and Viola Priesemann. The challenges of containing SARS-CoV-2 via test-trace-andisolate. arXiv:2009.05732 [q-bio], September 2020. arXiv:
2009.05732.
[2] Michael Meyer-Hermann, Iris Pigeot, Viola Priesemann,
and Anita Schöbel. Together we can do it: Each individual
contribution protects health, society, and the economy,
https://www.mpg.de/15503604/statement-non-univ
ersity-research-organizations-covid-19-epidemic.
html. 2020.

of cases since September is not driven by increased test
activity.

60-79

40-59

20-39

IFR (in percent)
Age group Levin et al. Eq. (2)
20-24 .007 .006 .009] .01
25-29 .014 [.011 .017] .0178
30-34 .025 [.021 .03] .0316
35-39 .045 [.038 .053] .0562
40-44 .081 [.07 .094] .1
45-49 .148 [.129 .17] .178
50-54 .269 [.234 .308] .316
55-59 .488 [.425 .561] .562
60-64 .887 [.764 1.03] 1.
65-69 1.61 [1.37 1.9] 1.78
70-74 2.93 [2.44 3.52] 3.16
75-79 5.33 [4.34 6.53] 5.62
80-84 9.68 [7.71 12.2] 10.
85-89 17.6 [13.7 22.6] 17.8
90-94 32. [24.2 42.2] 31.6
95-99
56.2
100+
60.

80+

distribution of reported cases is used to weight the IFR(a)
in each age group appropriately; this is different from
the case-fatality rate, which corresponds to the ratio of
observed deaths to reported cases.
We used this definition of an effective IFR to calculate
the effective IFR for Germany assuming eq. (2) and a
case distribution proportional to the population’s age
distribution: IFRDE
mix = 1.83. With equal spread across
all age groups, 65% of deaths would originate from the
80+ age group (Tabl. II). With values from [4] for the
age-specific IFR (instead of eq. (2)), the corresponding
effective IFR for Germany is IFRDE
Levin = 1.61[1.29; 2.02].
Both IFRDE represent an age-agnostic equal infection
spread.
h. Case fatality rate In order to compare the theoretical effective infection fatality rate to the actual reported
deaths, we calculated a case fatality rate. The approach
was to divide the number reported deaths occurring two
weeks later by the reported cases. This doesn’t take into
account the wide distribution of delays between infections and deaths. We mitigate the errors introduced by
this simple assumption by using at least 2 weeks of data
(Tab. I).
i. Testing The steep increase in the number of cases
throughout all age-groups starting in October is not driven
by increased testing activity: Between the end of June
and the end of September, the rate of positive tests stayed
below 1% except for the age group 15-34, which stayed between 1-1.5% [10]. Until mid-September, it even remained
below 0.5% in the age groups 60-79 and 80+. In conjunction with a consistently high number of tests of 600-700
per 100000 in the age group 80+, well above the 300-400
tests per 100000 in the other groups, we assume adequate
coverage of that age group, and as a result a constant
low number of undetected cases. The twofold increase in
overall testing from beginning to end of August, 500000 to
1 million tests per week [3], was driven by tests in the age
groups < 60, temporarily lowering the fraction of positive
tests in those groups until mid-September. From then
on the number of tests continues to be around 1 million
tests per week, leading to our conclusion that the increase

[%]
of pop.
5.43
5.76
6.50
6.48
6.04
6.19
7.97
8.12
6.95
5.76
5.58
4.34
3.89
1.95
.90
.24
.02

cum. [%]
of deaths
pred. obs.
.0
.126 .24
.23
.43 1.12
.76
1.36 2.58
2.74
5.23 10.1
9.03
14.6 20.2
22.5
35.9 43.0
57.1
76.1 83.1
91.8
99.2 99.3
100. 100.

TABLE II. Comparison of infection fatality rates
(IFR). The first column reproduces the age-dependent IFR
from Levin et al. [4] evaluated at the center of the age group
alongside 95% confidence interval bounds. The second column
list the IFR values used in the analysis, which are calculated
using eq. (2). The right half displays the predicted and observed percentage of deaths in each age group, cumulatively
summing over all preceding age groups. For the estimated
percentage for Germany, the age-specific IFR from the 3rd
column is multiplied with the fraction of population in the
age group. The observation refers to deaths in weeks 31-40
[3]. The observed fraction of deaths was almost twice as large
as the estimated one in the age group up to 60 years (last
two columns), reflecting that the virus spread more among
the younger people than expected. These columns also show
that 5.23 % (10.1%) of all deaths are expected among the
age group up to 60, thus almost 95 % (90 %) of all deaths
are expected to originate from the age groups 60+ assuming
age-independent (or age-dependent) spreading.

[3] RKI Tuesdays’ situation reports, retrieved 2020/10/07,
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges
Coronavirus/Situationsberichte/Gesamt.html.
[4] Andrew T Levin, William P. Hanage, Nana OwusuBoaitey, Kensington B. Cochran, Seamus P. Walsh, and
Gideon Meyerowitz-Katz. Assessing the age specificity of
infection fatality rates for COVID-19: Systematic review,
meta-analysis, and public policy implications. medRxiv,
2020. medRxiv: 10.1101/2020.07.23.20160895v5.
[5] Robert Koch-Institut (RKI). SurvStat@RKI 2.0 API.
[6] United nations world population database, https://popu
lation.un.org/wpp/Download/Standard/Population/.
[7] P Moraga, DI Ketcheson, HC Ombao, and CM Duarte.
Assessing the age- and gender-dependence of the severity

5
and case fatality rates of COVID-19 disease in Spain
[version 1; peer review: 1 approved]. Wellcome Open
Research, 5(117), 2020.
[8] Robert Koch-Institut (RKI) dl-de/by 2-0. ArcGIS
database of the RKI’s COVID-19 dashboard, https:
//www.arcgis.com/home/item.html?id=f10774f1c6
3e40168479a1feb6c7ca74.

[9] Timothy W Russell, Nick Golding, Joel Hellewell, Sam
Abbott, Lawrence Wright, Carl A B Pearson, Kevin van
Zandvoort, Christopher I Jarvis, Hamish Gibbs, Yang
Liu, Rosalind M Eggo, John W Edmunds, and Adam J
Kucharski. Reconstructing the early global dynamics of
under-ascertained covid-19 cases and infections. medRxiv,
2020.
[10] RKI Laborbasierte Surveillance SARS-CoV-2 report of
2020-09-30 retrieved 2020/10/06, https://ars.rki.de
/Content/COVID19/Main.aspx.

6
HAUPTTEXT

Eine zweite Welle von SARS-CoV-2 breitet sich in
Dutzenden von Ländern aus. Die zweite Welle zeigt sich
zwar stark in neu gemeldeten Fällen, aber im Vergleich
zur ersten Welle weniger in der Zahl der Todesfälle. Jedoch gefährden bereits diese steigenden Fallzahlen die
Eindämmung von COVID-19, denn bei zu hohen Fallzahlen werden lokal Kipppunkte überschritten, was die
Kontrolle erschwert, den gezielten Schutz von Risikogruppen behindert und zu einer selbstbeschleunigenden Ausbreitung führt [1, 2].
Ein Kipppunkt wird erreicht, wenn die täglichen
Neuinfektionen die Kapazität einer lokalen Gesundheitsbehörde übersteigen, so dass sie nicht mehr effektiv testen
und Kontakte nachverfolgen können (TTI, test-traceisolate). Diese Situation kann eintreten lange bevor die
Krankenhäuser überlastet sind, und ist daher besonders
kritisch [1]: Wenn das TTI zusammenbricht, können Tests
und Rückverfolgung nur unzureichend oder mit großen
Verzögerungen durchgeführt werden, wodurch Infektionsketten zunehmend nicht erkannt werden. Dadurch bleiben
mehr SARS-CoV-2-Träger unentdeckt und können das
Virus unbeabsichtigterweise übertragen – auch auf Risikogruppen. Da die unentdeckten Träger die Ausbreitung
entscheidend vorantreiben, steigen die Fallzahlen immer
schneller und Ansteckungen breiten sich auch in vorher
effektiv geschützten Risikogruppen aus. Im Folgenden
präsentieren wir Hinweise für eine zweite Welle und die
Überschreitung dieses Kipppunktes.
In Deutschland, wie in vielen anderen Ländern, ist
die Entstehung einer zweiten Welle in Frage gestellt
worden, da nur die Fallzahlen seit Juli gestiegen sind,
während die Krankenhäuser nicht überlastet waren und
die Todesfälle nahezu konstant blieben (Abb. 2). Wir
untersuchten diese offensichtliche Diskrepanz anhand von
altersstratifiziertn Fall- und Sterbezahlen [3] und einer
altersabhängigen Infektionssterblichkeitsrate (IFR, infection fatality rate). Die IFR basiert auf einer Metaanalyse von Seroprävalenzstudien und umfangreichen PCRTracing-Programmen [4]. Die IFR steigt für jedes 20.
Lebensjahr etwa um den Faktor und beträgt im Alter von
82 Jahren rund 10%. Aus dieser altersabhängigen IFR
prognostizieren wir die zeitliche Entwicklung der COVID19-assoziierten Todesfälle, indem wir die wöchentlich
beobachteten Fälle jeder Altersgruppe um zwei Wochen
verzögern und mit der entsprechenden IFR multiplizieren.
Weitere Informationen und Ergebnisse finden sich in den
“supplementary material”.
Der zeitliche Verlauf der vorhergesagten COVID-19assoziierten Todesfälle (farbig) stimmt mit den tatsächlich
beobachteten (schwarz) in jeder Altersgruppe gut überein
(Abb. 2, rechts). Selbst die absoluten Zahlen stimmen
überein, was auf einen niedrigen Anteil unbeobachteter
SARS-CoV-2-Infektionsketten hindeutet.
Unsere altersstratifizierte Analyse löst die scheinbare
Diskrepanz zwischen den insgesamt gemeldeten Infektionen und Todesfällen plausibel auf: Der Anstieg der

FIG. 2. Die Anzahl der wöchentlichen COVID-19-Fälle
(links) sowie die Anzahl der prognostizierten und beobachteten
COVID-19-assoziierten Todesfälle werden für jede Altersgruppe (Mitte) angezeigt. Die Vorhersage der Anzahl der
Todesfälle anhand der Fallzahlen (farbig) stimmt mit den
gemeldeten Todesfällen (schwarz) in jeder Altersgruppe gut
überein, wobei eine altersabhängige Infektionsfatalitätsrate
basierend auf einer Meta-Analyse [4] zugrunde gelegt wurde.
Trotz eines Anstiegs der Gesamtzahl der gemeldeten Fälle
seit Mitte Juli (unten) stiegen die Fälle in den älteren Altersgruppen erst seit September an (blaue Pfeile). Infolgedessen
erwarten wir, dass bald ein deutlicher Anstieg der Todesfälle
beobachtet werden kann. Die Prognoseszenarien A und B
(grau, rechte Spalte) sagen einen weiteren Anstieg der Fallzahlen und Todesfälle voraus. Der jüngste Anstieg der Infektionen in den älteren Altersgruppen zusammen mit dem
Gesamtanstieg der Fälle weist eindeutig auf einen Kontrollverlust über die Ausbreitung und den Beginn einer zweiten Welle
hin

gemeldeten Fälle wurde hauptsächlich von den jüngeren
Generationen (jünger als 60 Jahre) verursacht, die nur
wenig zu den absoluten Todesfällen beitragen, während
es bei den älteren Menschen (60+ Jahre) bis vor Kurzem
gelang, die Fallzahlen niedrig zu halten. Im September
stiegen die Fälle bei älteren Menschen jedoch steil an.
Diese Beobachtung lässt sich nicht auf die Zunahme der
durchgeführten Tests zurückführen, da die Anzahl der
Tests in dieser Altersgruppe nahezu konstant blieb [3].
Dieses Überschwappen auf ältere Menschen legt nahe,
dass es aufgrund der wachsenden Zahl unbemerkter SARSCoV-2 Infizierter nicht gelungen ist, die Risikogruppen
zu schützen. Darüber hinaus ist dieser Kontrollverlust seit Anfang Oktober auch durch einen Anstieg der
Reproduktionszahl R gekennzeichnet (Tabelle III). Das

7
Überschwappen auf die ältere Generation und die Zunahme in R sind beides klare Zeichen dafür, dass der Kipppunkt zur unkontrollierten Ausbreitung überschritten
wurde.
Im Sommer 2020 waren die Altersgruppen 60+ offenbar gut geschützt: Hätte sich das Virus unabhängig und
gleichmäßig über alle Altersgruppen verbreitet, wären
schätzungsweise 1,3% bis 2,0% der Infizierten gestorben,
wenn man von der in [4] berichteten IFR ausgeht. Die
Todesfallrate (CFR, case fatality rate) lag im August jedoch nur bei 0,39% (Tabelle III). Jetzt, mit der stark
zunehmenden Anzahl der Infektionen unter älteren Menschen (Abb. 2), wird die CFR höchstwahrscheinlich bald
ansteigen. Dies weist darauf hin, dass ein Schutz der
Risikopersonen möglich ist, solange die Fallzahlen niedrig
sind, aber wahrscheinlich bei hoher COVID-19-Inzidenz
scheitert.
Für die kommenden zwei Wochen kann alleine aufgrund
der bereits gemeldeten Fälle der letzten zwei Wochen
vorhergesagt werden, dass sich die Zahl der wöchentlichen
Todesfälle fast verdoppeln wird. Prognosen über mehr als
zwei Wochen hinaus gestalten sich als schwierig, da die
Zahl der Todesfälle von den noch nicht gemeldeten Fällen
abhängt. Um diese Unsicherheit einzugrenzen, setzen wir
zwei Zukunftsszenarien an, wobei wir in (A) einen linearen
Anstieg und in (B) einen exponentiellen Anstieg der Fälle
annehmen (Methoden in den “supplementary material”).
Die sich daraus ergebenden Vorhersagen bewegen sich
zwischen 500 und 800 wöchentlichen Todesfällen Anfang
November. Die Fallzahlen könnten jedoch noch schneller
ansteigen, falls sich die zweite Welle voll entfaltet.
Wenn die Kapazitätsgrenze für Testung und Kontaktnachverfolgung (TTI) überschritten ist, brechen die
Eindämmungsmaßnahmen dieses Kontrollsystems zusammen und der Anstieg der Fallzahlen beschleunigt sich [1].
Die aktuelle Entwicklung in Deutschland bringt somit
die in der Vergangenheit erfolgreiche Bewältigung der
Pandemie ernsthaft in Gefahr. Um die Kontrolle wieder

zu erlangen und um ein Überschreiten des Kipppunktes bei Überlastung der TTI-Kapazität zu vermeiden,
müssen die Fallzahlen unverzüglich gesenkt werden. Andernfalls werden die Eindämmung der Ausbreitung und
der Schutz der Risikogruppen zwangsläufig sehr viel restriktivere Maßnahmen erfordern – spätestens wenn die
Krankenhauskapazität erreicht ist.

Anzahl
Wochen
Zeitraum
Juli
4
August 4
Anf. Sep 3
Ende Sep 2
Anf. Okt 2

Anzahl
Tode
prog. beob.
14163 122 146
32273 156 127
30493 214 184
28737 281 286
66796 741 Fälle

CFR
(in %)
1,0
0,39
0,6
0,99
-

R
(RKI)
1,11
1,06
1,10
1,16
1,31

TABLE III. Vergleich der prognostizierten und
beobachteten Todesfälle.
Diese Tabelle fasst die in
(Abb. 2 vorgestellten Zahlen zusammen. Für jeden Zeitraum
im Sommer 2020 werden die Anzahl der gemeldeten COVID19 Neuinfektionen (“Fälle”) zusammen mit der Anzahl der
Todesfälle aufgeführt, die beobachtet (beob.) und auf Basis von [4] prognostiziert (prog.) werden. Um dem zeitlich
verzögerten Zusammenhang zwischen Fall- und Todesmeldung
Rechnung zu tragen, werden alle Todesfälle zwei Wochen
früher terminiert. Die prognostizierten Todesfälle weichen von
den beobachteten Todesfällen um weniger als 20% ab. Die
Fallsterblichkeit (CFR) wird als Verhältnis der beobachteten
Todesfälle zu den gemeldeten Fällen berechnet. Zum Vergleich:
Wenn die Fälle gleichmäßig über die Altersgruppen verteilt
wären und keine Fälle unentdeckt blieben, würde die CFR der
theoretischen Infektionssterblichkeit (IFR) entsprechen, die für
Deutschland bei 1,61 liegt mit einem 95%-Konfidenzintervall
von [1,29;2,02] [4]. Die letzte Spalte zeigt die Reproduktionszahl R, wie vom Robert Koch-Institut (RKI) gemeldet.

